Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy
Clinical trial NCT03725761 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03725761
- Sponsor
- University of Wisconsin, Madison
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-24
- Primary completion
- 2024-04-18
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.